---
category: news
title: "Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines"
excerpt: "Collaborative efforts aim to accelerate drug discovery and improve clinical success Agreement to utilize Exscientia’s AI-based capabilities and personalised medicine platform from target identification through patient selection Research will be focused on up to 15 novel small molecule candidates across oncology and immunology Exscientia will receive an upfront cash payment of $100 million with the potential of $5."
publishedDateTime: 2022-01-07T06:02:00Z
originalUrl: "https://apnews.com/press-release/globe-newswire/coronavirus-pandemic-business-health-531f9bb727e741335053eb4f43091797"
webUrl: "https://apnews.com/press-release/globe-newswire/coronavirus-pandemic-business-health-531f9bb727e741335053eb4f43091797"
type: article
quality: 8
heat: -1
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

related:
  - title: "Sanofi partners with AI firm Exscientia to develop up to 15 new drugs"
    excerpt: "French drugmaker Sanofi SA SASY.PA will partner with British AI firm Exscientia Plc EXAI.O to develop up to 15 drug candidates across oncology and immunology, in a deal worth up to $5.2 billion in milestone payments,"
    publishedDateTime: 2022-01-07T05:01:00Z
    webUrl: "https://www.nasdaq.com/articles/sanofi-partners-with-ai-firm-exscientia-to-develop-up-to-15-new-drugs"
    ampWebUrl: "https://www.nasdaq.com/articles/sanofi-partners-with-ai-firm-exscientia-to-develop-up-to-15-new-drugs?amp"
    cdnAmpWebUrl: "https://www-nasdaq-com.cdn.ampproject.org/c/s/www.nasdaq.com/articles/sanofi-partners-with-ai-firm-exscientia-to-develop-up-to-15-new-drugs?amp"
    type: article
    provider:
      name: Nasdaq
      domain: nasdaq.com
    quality: 67
  - title: "Healthcare group Sanofi forms research deal with the company Exscientia"
    excerpt: "French healthcare company Sanofi, which has been under pressure to revive its drug pipeline after some setbacks in the COVID-19 vaccine race, announced on Friday a research deal with the company Exscientia to develop new medicines."
    publishedDateTime: 2022-01-07T06:44:00Z
    webUrl: "https://www.channelnewsasia.com/business/healthcare-group-sanofi-forms-research-deal-company-exscientia-2420706"
    type: article
    provider:
      name: Channel NewsAsia Singapore
      domain: channelnewsasia.com
    quality: 39
    images:
      - url: "https://onecms-res.cloudinary.com/image/upload/s--VLEtxmPC--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2022-01-07t064223z_2_lynxmpei06064_rtroptp_3_sanofi-results.jpg?itok=gm1J4PRI"
        width: 1200
        height: 676
        isCached: true
  - title: "Sanofi partners with AI firm Exscientia to develop up to 15 new drugs"
    excerpt: "French drugmaker Sanofi SA will partner with British AI firm Exscientia Plc to develop up to 15 drug candidates across oncology and immunology, in a deal worth up to US$5.2 billion in milestone payments,"
    publishedDateTime: 2022-01-07T18:59:00Z
    webUrl: "https://www.channelnewsasia.com/business/sanofi-partners-ai-firm-exscientia-develop-15-new-drugs-2420736"
    type: article
    provider:
      name: Channel NewsAsia Singapore
      domain: channelnewsasia.com
    quality: 37
    images:
      - url: "https://onecms-res.cloudinary.com/image/upload/s--ULGSC9r3--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2022-01-07t065402z_3_lynxmpei0605t_rtroptp_3_sanofi-results.jpg?itok=QpDT4toX"
        width: 1200
        height: 676
        isCached: true
  - title: "Sanofi bets big on AI again, paying $100M to start drug R&D pact with Exscientia"
    excerpt: "Sanofi’s new alliance with artificial intelligence biotech Exscientia spans up to 15 small molecule drugs in cancer and immunology. If drugs from the partnership reach the market, Exscientia could earn as much as $5."
    publishedDateTime: 2022-01-07T16:15:00Z
    webUrl: "https://medcitynews.com/2022/01/sanofi-bets-big-on-ai-again-paying-100m-to-start-drug-rd-pact-with-exscientia/"
    type: article
    provider:
      name: MedCity News
      domain: medcitynews.com
    quality: 32
    images:
      - url: "https://medcitynews.com/uploads/2021/04/GettyImages-1230836886.jpg"
        width: 1024
        height: 683
        isCached: true
  - title: "Sanofi makes AI play, putting up $100M and billions in biobucks to form broad deal with Exscientia"
    excerpt: "Sanofi is getting deeper into AI-driven R&D. After working with AI drug discovery shop Exscientia for five years, Sanofi has significantly expanded its relationship, putting up $100 million and $5.2 billion on the backend for the chance to work on up to 15 small molecules across oncology and immunology."
    publishedDateTime: 2022-01-07T05:01:00Z
    webUrl: "https://www.fiercebiotech.com/biotech/sanofi-makes-ai-play-putting-up-100m-and-billions-biobucks-to-form-broad-deal-exscientia"
    type: article
    provider:
      name: FierceBiotech
      domain: fiercebiotech.com
    quality: 23
    images:
      - url: "https://qtxasset.com/fiercebiotech/1641487855/Sanofi.jpg/Sanofi.jpg?VersionId=iGMK6OHqHmXYmaa5FawGN5L8VNKX49li"
        width: 800
        height: 541
        isCached: true
  - title: "Sanofi, Ex­sci­en­tia ink the next AI megadeal, sign­ing terms on a $100M up­front pact with up to 15 drugs on the line"
    excerpt: "Drug R&D has for years had an abysmal track record of success, with the vast majority of drug candidates never making it to market. The promise of AI to shorten the discovery time for new drugs and up"
    publishedDateTime: 2022-01-07T06:01:00Z
    webUrl: "https://endpts.com/sanofi-exscientia-ink-the-next-ai-megadeal-signing-terms-on-a-100m-upfront-pact-with-up-to-15-drugs-on-the-line/"
    type: article
    provider:
      name: ENDPOINTS NEWS
      domain: endpts.com
    quality: 0

secured: "B+tIO/YnkGBjsxCxgF7zy7HmIQzHrNyiXk0vKs3kTQGGBwNj+8Rv9LD3slQHaTb4HXTOwnKUOHjo4EpSER52BcmpH+zD8V+vSQ374vrCtGi6HrpJVaGwwZI2aLMzs6iTPmiypqYcCi3v+d5VD/MUqptL7Md9sbjdWlnfjMLPmh6ZHSZTGv2OsZpg90EtzFYYdAnn6XtfPMMMu7d0RWOKMl1Ga0Xo2orBJykiTiDYiF3+DdYLtFKz95F/OUDBskBxf57yqF5TBre1yYB64OvYvQuaUoeaoUHm7TAzi1PYO3UG48svp6ccFDGQw+L6jJCQeALOVGfq9R2Cg5l4coPKEcSTDAWxe09JLk6AoX9lKbk=;LRW1ARIAmBbYinIhpkzKIQ=="
---

